SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (27076)12/30/1998 8:08:00 PM
From: dwc  Read Replies (1) | Respond to of 32384
 
Cover story in February 99 issue of Kiplinger's Personal Finance Magazine touts the "Miracle (Biotech) Companies (5) to Invest in Now"

Ligand is one of the five:
Chiron.
Centocor
Isis
PathoGenesis

A really complimentary article.



To: bob zagorin who wrote (27076)12/31/1998 2:01:00 AM
From: B.D.  Read Replies (3) | Respond to of 32384
 
I think the new SEC filing is *very* very interesting, and I recommend all LGND/LGNDW shareholders read it. Sure, it's a prospectus and sure, it contains standard disclaimers, but geez, they're sobering, and should be required reading.

For one thing I didn't know about the patent dispute between Ligand and Hoffman-LaRoche regarding Panretin. I don't remember that being discussed here. Was it?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News